TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
This Quarter Return
-8.24%
1 Year Return
+15.45%
3 Year Return
+77.97%
5 Year Return
+97.59%
10 Year Return
–
AUM
$531M
AUM Growth
+$531M
(-10%)
Cap. Flow
-$2.26M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
41.63%
Holding
83
New
3
Increased
23
Reduced
40
Closed
3
Top Buys
| 1 |
CPHD
Cepheid Inc
CPHD
|
$1.83M |
| 2 |
TIF
Tiffany & Co.
TIF
|
$619K |
| 3 |
Paychex
PAYX
|
$329K |
| 4 |
Apple
AAPL
|
$224K |
| 5 |
Pfizer
PFE
|
$218K |
Top Sells
| 1 |
DexCom
DXCM
|
$1.27M |
| 2 |
Nektar Therapeutics
NKTR
|
$1.14M |
| 3 |
Stratasys
SSYS
|
$532K |
| 4 |
Brown-Forman Class B
BF.B
|
$440K |
| 5 |
Novo Nordisk
NVO
|
$311K |
Sector Composition
| 1 | Healthcare | 38.01% |
| 2 | Technology | 11.94% |
| 3 | Industrials | 11.93% |
| 4 | Consumer Staples | 9.32% |
| 5 | Energy | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$19.4B
| $29.3M | 5.51% |
100,286
-835
| -0.8% | -$244K |
|
|
TIF
2
DELISTED
Tiffany & Co.
TIF
| $27.5M | 5.17% |
355,536
+8,020
| +2% | +$619K |
|
|
3
Brown-Forman Class B
BF.B
$14.2B
| $24.3M | 4.59% |
251,199
-4,542
| -2% | -$440K |
|
|
4
DexCom
DXCM
$29.5B
| $22.1M | 4.17% |
257,945
-14,830
| -5% | -$1.27M |
|
5
Danaher
DHR
$147B
| $21.8M | 4.11% |
255,856
-20
| -0% | -$1.7K |
|
|
6
Novo Nordisk
NVO
$251B
| $21.6M | 4.07% |
398,130
-5,725
| -1% | -$311K |
|
7
Johnson & Johnson
JNJ
$427B
| $20.9M | 3.93% |
223,719
-1,165
| -0.5% | -$109K |
|
8
Analog Devices
ADI
$124B
| $19.4M | 3.65% |
343,581
+90
| +0% | +$5.08K |
|
9
Cognex
CGNX
$7.38B
| $17.7M | 3.34% |
515,820
+600
| +0.1% | +$20.6K |
|
10
Neogen
NEOG
$1.25B
| $16.4M | 3.09% |
364,256
-2,385
| -0.7% | -$107K |
|
11
W.W. Grainger
GWW
$48.5B
| $16.2M | 3.06% |
75,570
+50
| +0.1% | +$10.8K |
|
12
Honeywell
HON
$139B
| $15.9M | 2.99% |
167,535
-1,675
| -1% | -$159K |
|
|
RTN
13
DELISTED
Raytheon Company
RTN
| $15.8M | 2.98% |
144,616
-320
| -0.2% | -$35K |
|
14
Henry Schein
HSIC
$8.44B
| $14.2M | 2.68% |
107,359
-780
| -0.7% | -$104K |
|
15
Schlumberger
SLB
$55B
| $14.1M | 2.66% |
204,582
+1,750
| +0.9% | +$121K |
|
16
Idexx Laboratories
IDXX
$51.8B
| $13.6M | 2.57% |
183,505
-460
| -0.3% | -$34.2K |
|
17
Amgen
AMGN
$155B
| $12.4M | 2.34% |
89,767
-450
| -0.5% | -$62.2K |
|
|
SYT
18
DELISTED
Syngenta Ag
SYT
| $12M | 2.25% |
187,519
-795
| -0.4% | -$50.7K |
|
19
Williams-Sonoma
WSM
$23.1B
| $11.2M | 2.12% |
147,095
-2,125
| -1% | -$162K |
|
|
CTXS
20
DELISTED
Citrix Systems Inc
CTXS
| $9.66M | 1.82% |
139,373
-100
| -0.1% | -$6.93K |
|
21
Kimberly-Clark
KMB
$42.8B
| $8.8M | 1.66% |
80,687
+75
| +0.1% | +$8.18K |
|
22
Ross Stores
ROST
$48.1B
| $8.46M | 1.59% |
174,500
-1,230
| -0.7% | -$59.6K |
|
23
GE Aerospace
GE
$292B
| $8.19M | 1.54% |
324,903
-1,590
| -0.5% | -$40.1K |
|
24
AbbVie
ABBV
$372B
| $7.69M | 1.45% |
141,315
+650
| +0.5% | +$35.4K |
|
25
State Street
STT
$32.6B
| $7.43M | 1.4% |
110,555
-235
| -0.2% | -$15.8K |
|